![Ate van der Zee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Ate van der Zee.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
ViciniVax BV
![]() ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands.
5
| Holding Company | Pharmaceuticals: Other | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ate van der Zee a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
University of Groningen | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
University of Utrecht | College/University | Graduate Degree Graduate Degree | |
VenGen BV
![]() VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Investment Managers | Founder | |
UbiQ Bio BV
![]() UbiQ Bio BV Pharmaceuticals: MajorHealth Technology UbiQ Bio BV specializes in the ubiquitin related reagents, peptides and assays. The firm focuses on pharma companies and academic research labs. The company was founded by by Huib Ovaa and Farid El Oualidin in 2010 and is headquartered in Amsterdam, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
Photonics Healthcare BV
![]() Photonics Healthcare BV Medical SpecialtiesHealth Technology Photonics Healthcare BV engages in the development of medical devices for monitoring mitochondrial function in to clinical practice. It offers Comet monitor, which allows doctors to optically measure the oxygen in the mitochondria inside a patient's cells. The company was founded by Egbert Gezinus Mik, Michael Münker, and Alfred N. Nijkerk in October 2009 and is headquartered in Utrecht, the Netherlands. | Medical Specialties | Founder | |
University of Amsterdam | College/University | Doctorate Degree | |
MeiraGTx Netherlands BV
![]() MeiraGTx Netherlands BV Pharmaceuticals: MajorHealth Technology MeiraGTx Netherlands BV operates as a biopharmaceutical company developing local gene therapy for inflammatory diseases. It is into develop adeno-associated viral mediated gene therapy for patients with rheumatic conditions. The company was founded in 2005 and is headquartered in Amsterdam, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer |
Estadísticas
Internacional
Países Bajos | 12 |
Sectorial
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 3 |
Finance | 2 |
Consumer Non-Durables | 2 |
Operativa
Founder | 8 |
Corporate Officer/Principal | 5 |
Chief Executive Officer | 4 |
Graduate Degree | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Las relaciones más conectadas
Insiders | |
---|---|
Alfred N. Nijkerk | 7 |
Janneke Meulenberg | 6 |
Toos Daemen | 3 |
Hans Nijman | 2 |
Jan C. Wilschut | 1 |
- Bolsa de valores
- Insiders
- Ate van der Zee
- Conexiones Empresas